58442-16-3 Usage
Uses
Used in Pharmaceutical Research:
Ethanone,1-(1H-benzimidazol-5-yl)is used as a research compound for exploring its potential biological activities and therapeutic applications. Its unique structure and properties make it a valuable tool in the discovery and development of new drugs.
Used in Drug Development:
Ethanone,1-(1H-benzimidazol-5-yl)is utilized as a starting material or intermediate in the synthesis of various pharmaceutical agents. Its potential biological activities and interactions with biological targets can be leveraged to develop novel therapeutic agents for the treatment of various diseases and conditions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, Ethanone,1-(1H-benzimidazol-5-yl)is employed as a structural motif for the design and optimization of new drug candidates. Its unique features can be incorporated into drug molecules to enhance their pharmacological properties, such as potency, selectivity, and bioavailability.
Used in Chemical Synthesis:
Ethanone,1-(1H-benzimidazol-5-yl)is also used as a versatile building block in organic synthesis. Its reactivity and functional groups can be exploited to synthesize a wide range of organic compounds, including pharmaceuticals, agrochemicals, and other specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 58442-16-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,4,4 and 2 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 58442-16:
(7*5)+(6*8)+(5*4)+(4*4)+(3*2)+(2*1)+(1*6)=133
133 % 10 = 3
So 58442-16-3 is a valid CAS Registry Number.
58442-16-3Relevant academic research and scientific papers
INHIBITORS OF HISTONE DEACETYLASE
-
, (2016/04/26)
This invention provides compounds that are inhibitors of HDAC2. The compounds (e.g., compounds according to Formula (I), (II), (IIa), (III), (IV), (V), or (VI)) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological disease, or neoplastic disease, or for improving memory or treating, alleviating, or preventing memory loss or impairment.
FUSED HETEROARYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION
-
Page/Page column 24, (2012/06/01)
This invention relates to thiazole I and its therapeutic and prophylactic uses, wherein the variables A, Q, J, R1, R3, and R5 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.
